Vgone Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-01-2025
- Paid Up Capital ₹ 0.10 M
as on 09-01-2025
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 39.57%
(FY 2022)
- Profit 92.94%
(FY 2022)
- Ebitda 115.82%
(FY 2022)
- Net Worth -4.46%
(FY 2022)
- Total Assets -79.79%
(FY 2022)
About Vgone Pharma
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sushil Salvi and Nithyanand Sudalimani serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC304917
- Company No.
304917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vgone Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Salvi  | Director | 10-Jan-2024 | Current |
| Nithyanand Sudalimani | Director | 10-Jan-2024 | Current |
Financial Performance of Vgone Pharma.
Vgone Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.57% increase. The company also saw a substantial improvement in profitability, with a 92.94% increase in profit. The company's net worth dipped by a decrease of 4.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vgone Pharma?
Unlock access to Vgone Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Verleihen Health Care Private LimitedActive 8 years 6 months
Sushil Salvi and Nithyanand Sudalimani are mutual person
- Biohead Health Solutions Private LimitedActive 5 years 8 months
Sushil Salvi and Nithyanand Sudalimani are mutual person
- Ay Medivision Private LimitedActive 8 years 1 month
Sushil Salvi and Nithyanand Sudalimani are mutual person
- Northgate Express Freights Private LimitedActive 2 years 4 months
Nithyanand Sudalimani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vgone Pharma?
Unlock and access historical data on people associated with Vgone Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vgone Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vgone Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
